Geriatric Polypharmacy Interventions: How to Reduce Adverse Drug Events in Older Adults

Geriatric Polypharmacy Interventions: How to Reduce Adverse Drug Events in Older Adults

Polypharmacy Risk Calculator

This tool calculates your risk of adverse drug events based on the number of medications you or a loved one is taking. According to research, each additional medication increases the risk of falls by 8%.

When an older adult takes five or more medications, they’re not just managing health-they’re navigating a minefield. Polypharmacy, defined as the routine use of five or more drugs, affects 41% of adults aged 65 and older in the U.S., and nearly 19% take ten or more. The problem isn’t the number of pills alone-it’s the hidden dangers. Each extra medication increases the risk of a fall by 8%, and medication-related hospitalizations account for nearly 28% of all hospital admissions in this age group. The good news? We know how to fix it.

Why Polypharmacy Is Dangerous for Older Adults

Older adults aren’t just taking more pills because they’re sicker. They’re taking more because different doctors prescribe for different conditions, and no one steps back to ask: Is this still necessary? A patient might be on a blood thinner for atrial fibrillation, a statin for cholesterol, a diuretic for heart failure, an antacid for reflux, and a sleep aid-all prescribed by different providers. No one checks if the sleep aid is making the antacid less effective, or if the diuretic is worsening kidney function. That’s where harm happens.

Research from the Journal of the American Geriatrics Society shows that patients on four or more medications have a 30-50% higher risk of injurious falls. The risk doesn’t stop there. Drug interactions can cause confusion, dizziness, low blood pressure, or even kidney failure. And here’s the twist: while some medications are unnecessary, others are missing. Nearly 39% of older adults aren’t getting drugs they actually need-like vaccines, blood pressure meds, or bone-strengthening agents. This isn’t just overmedication-it’s undertreatment too.

The Three Levels of Medication Review-Only One Works

Not all medication reviews are created equal. There are three types, and only one makes a real difference.

  • Type I: Just reviewing the list of meds. No conversation. No clinical context. This does nothing.
  • Type II: Adds a check on whether the patient is taking the meds as prescribed. Still doesn’t address whether they should be taking them.
  • Type III: Face-to-face or video consultation with a pharmacist or clinician who looks at the full picture: symptoms, lab results, life goals, and functional status. This is the only type proven to cut hospital readmissions by 18.3%.
A 2023 study in JAMA Network Open followed over 12,000 older adults. Only those who had Type III reviews-where someone sat down with them, asked how they felt, checked their balance, and reviewed their kidney function-saw real improvements. The others? No change. That’s not a minor gap. It’s a failure of system design.

The Tools That Actually Work

There are dozens of guidelines for when to stop or start a drug. But only a few have been tested in real-world trials and shown to reduce harm.

  • Beers Criteria (2023 update): Lists drugs to avoid in older adults. Useful, but doesn’t tell you when to restart something.
  • STOPP/START v3 (2021): Stops inappropriate prescriptions (STOPP) and starts needed ones (START). Proven in RCTs to reduce hospitalizations.
  • FORTA List: Classifies drugs as “Fit,” “Optimal,” “Reasonable,” or “Avoid” based on evidence and frailty. Only one tool that links drug choice to functional status.
The European Geriatric Medicine journal found that clinics using STOPP/START or FORTA had 22% more appropriate deprescribing than those using Beers alone. Why? Because Beers tells you what to avoid. STOPP/START and FORTA tell you what to fix-and what to add.

An elderly man overwhelmed by prescriptions raining down from multiple doctors, stabilized by a pharmacist with a FORTA checklist.

Who Does the Best Job? Pharmacists, Not Just Doctors

You wouldn’t ask a mechanic to fix your plumbing. Why do we expect doctors to manage every drug interaction?

Pharmacists trained in geriatrics are the unsung heroes here. A 2025 study showed that under Collaborative Practice Agreements (CPAs), pharmacists deprescribe at a rate 37.6% higher than physicians working alone. Why? They have the time. They have the training. And they’re not juggling 20 patients an hour.

But here’s the catch: only 72 U.S. states allow CPAs for pharmacists. In 28 states, pharmacists can’t legally adjust prescriptions-even if they spot a dangerous interaction. That’s not a clinical issue. It’s a policy failure.

Even in states where CPAs exist, reimbursement is a nightmare. Only 15% of Medicare Advantage plans pay for comprehensive medication reviews. Most clinics can’t afford to spend 45-60 minutes per patient unless they’re funded by grants or government programs like the VA.

What Works in Real Clinics

The Veterans Health Administration (VHA) has been doing this right for years. Their Geriatric Research, Education and Clinical Centers (GRECCs) embedded pharmacists directly into geriatric teams. Result? A 26.8% drop in potentially inappropriate medications. How? They didn’t just remove pills. They rebuilt the whole process.

Their method:

  1. Get an accurate medication list-no guesswork. Use pill bottles, pharmacy records, and family input.
  2. Run the list through STOPP/START and FORTA.
  3. Have a conversation with the patient: “What are your goals? Do you want to live longer, or feel better now?”
  4. Taper slowly. Don’t yank meds. Especially not benzodiazepines or antipsychotics.
  5. Follow up in 2 weeks. Watch for withdrawal symptoms.
Duke University’s “Five Tips” approach mirrors this: accurate list, EHR cleanup, team huddles, patient education, and scheduled rechecks.

Meanwhile, community clinics? They’re stuck. A 2022 AAFP survey found 78% of primary care doctors spend less than 5 minutes per patient on medication review. That’s not enough time to read one prescription, let alone assess 10.

The Hidden Barriers

Even when clinics want to help, they hit walls.

  • Fragmented care: 78% of older adults see five or more providers a year. No one has the full picture.
  • Poor documentation: Only 33% of electronic health records track whether patients actually take their meds.
  • Patient fear: 68% of older adults are terrified of stopping a medication-even if it’s harmful. “My doctor told me to take this. What if I get worse?”
And then there’s the data gap. We know AI can predict risk. Epic’s “Polypharmacy Risk Score,” launched in April 2024, predicts adverse events with 87.3% accuracy. But most clinics don’t use it. Why? It’s not integrated into billing. It’s not part of performance metrics. It’s just a tool sitting in the background.

An elderly man's pills transforming into a cane and rose, with a digital risk score glowing in the background.

What’s Next? The Future Is Here

The American Geriatrics Society is finalizing Beers Criteria v2026, with a new focus: deprescribing algorithms tailored to life expectancy and cognitive status. The National Institute on Aging is funding trials on genomic-based risk calculators-imagine knowing a patient’s DNA tells them to metabolize certain drugs dangerously fast.

Medicare is already changing. Starting in 2024, the Merit-Based Incentive Payment System (MIPS) penalizes providers if 30% or more of their Medicare patients are on ten or more medications. That’s not a suggestion. It’s a financial consequence.

And the numbers are clear: clinics that have fully adopted these interventions report 19.3% higher patient satisfaction and 27.6% lower total cost of care. That’s not just better health. It’s better economics.

What You Can Do Right Now

If you’re caring for an older adult:

  • Ask: “Is this medication still helping? Is it causing more harm than good?”
  • Bring every pill bottle to every appointment-even the ones they haven’t opened in months.
  • Ask for a pharmacist consult. Say: “Can we get a comprehensive medication review?”
  • Don’t rush deprescribing. Taper slowly. Monitor for rebound symptoms.
  • Use STOPP/START or FORTA as a checklist. They’re free and online.
If you’re a clinician:

  • Stop doing Type I and II reviews. They’re a waste of time.
  • Partner with a clinical pharmacist. Even one hour a week changes outcomes.
  • Use EHR alerts for high-risk combinations-like NSAIDs with blood thinners.
  • Document goals of care: “Patient wants to avoid hospitalizations, prioritize mobility.”

It’s Not About Fewer Pills. It’s About Better Care.

Polypharmacy isn’t a numbers game. It’s a failure of coordination, communication, and compassion. Reducing medications isn’t about cutting corners. It’s about restoring balance. It’s about listening to the patient, not just the prescription pad.

The data is clear. The tools exist. The people who can fix this-pharmacists, geriatricians, nurses-are ready. What’s missing is the system that lets them do their job.

The next time you see an older adult on ten medications, don’t assume they need them all. Ask: Who reviewed this? When? And did they ask what matters most to the patient? Because the answer might save their life.

Graham Milton
Graham Milton

I am Graham Milton, a pharmaceutical expert based in Bristol, UK. My focus is on examining the efficacy of various medications and supplements, diving deep into how they affect human health. My passion aligns with my profession, which led me to writing. I have authored many articles about medication, diseases, and supplements, sharing my insights with a broader audience. Additionally, I have been recognized by the industry for my notable work, and I continue to strive for innovation in the field of pharmaceuticals.

AcleSpa.com: Your Pharmaceuticals Guide

Latest Posts

Contact Us

SEND MESSAGE